KR20180093465A - Cosmetic composition comprising fermented extract of Scutellaria baicalensis using Leatiporus sulphureus for inhibiting skin damage by ultraviolet - Google Patents
Cosmetic composition comprising fermented extract of Scutellaria baicalensis using Leatiporus sulphureus for inhibiting skin damage by ultraviolet Download PDFInfo
- Publication number
- KR20180093465A KR20180093465A KR1020170019603A KR20170019603A KR20180093465A KR 20180093465 A KR20180093465 A KR 20180093465A KR 1020170019603 A KR1020170019603 A KR 1020170019603A KR 20170019603 A KR20170019603 A KR 20170019603A KR 20180093465 A KR20180093465 A KR 20180093465A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- skin
- cosmetic composition
- gold
- skin damage
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 239000002537 cosmetic Substances 0.000 title claims abstract description 31
- 230000037380 skin damage Effects 0.000 title claims abstract description 25
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 19
- 239000000284 extract Substances 0.000 title claims description 72
- 240000004534 Scutellaria baicalensis Species 0.000 title claims description 6
- 235000017089 Scutellaria baicalensis Nutrition 0.000 title claims description 6
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 43
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 41
- 239000010931 gold Substances 0.000 claims description 41
- 229910052737 gold Inorganic materials 0.000 claims description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 238000000855 fermentation Methods 0.000 claims description 15
- 230000004151 fermentation Effects 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000008213 purified water Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 5
- 241000186359 Mycobacterium Species 0.000 claims 1
- 238000011081 inoculation Methods 0.000 claims 1
- 230000008719 thickening Effects 0.000 abstract description 7
- 239000010404 Scutellaria baicalensis extract Substances 0.000 abstract 3
- 210000003491 skin Anatomy 0.000 description 45
- 239000000047 product Substances 0.000 description 32
- 206010051246 Photodermatosis Diseases 0.000 description 15
- 230000008845 photoaging Effects 0.000 description 15
- 230000000694 effects Effects 0.000 description 11
- 235000019441 ethanol Nutrition 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 230000032683 aging Effects 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 230000009759 skin aging Effects 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 150000002338 glycosides Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000001965 potato dextrose agar Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 240000001592 Amaranthus caudatus Species 0.000 description 3
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- -1 polyoxyethylene monooleate Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 241000272525 Anas platyrhynchos Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241000590002 Helicobacter pylori Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000000254 damaging effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 229940037467 helicobacter pylori Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- JYLNVJYYQQXNEK-UHFFFAOYSA-N 3-amino-2-(4-chlorophenyl)-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(CN)C1=CC=C(Cl)C=C1 JYLNVJYYQQXNEK-UHFFFAOYSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920001007 Nylon 4 Polymers 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010040867 Skin hypertrophy Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HIMJIPRMECETLJ-UHFFFAOYSA-N Wogonin Natural products COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3 HIMJIPRMECETLJ-UHFFFAOYSA-N 0.000 description 1
- LNOHXHDWGCMVCO-UHFFFAOYSA-N Wogonoside Natural products C1=C(O)C(C(C=C(O2)C=3C=CC=CC=3)=O)=C2C(OC)=C1OC1OC(C(O)=O)C(O)C(O)C1O LNOHXHDWGCMVCO-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 1
- 229940015301 baicalein Drugs 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- RNPXCFINMKSQPQ-UHFFFAOYSA-N dicetyl hydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCC RNPXCFINMKSQPQ-UHFFFAOYSA-N 0.000 description 1
- 229940093541 dicetylphosphate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- XLTFNNCXVBYBSX-UHFFFAOYSA-N wogonin Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 XLTFNNCXVBYBSX-UHFFFAOYSA-N 0.000 description 1
- LNOHXHDWGCMVCO-NTKSAMNMSA-N wogonin 7-O-beta-D-glucuronide Chemical compound C1=C(O)C(C(C=C(O2)C=3C=CC=CC=3)=O)=C2C(OC)=C1O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LNOHXHDWGCMVCO-NTKSAMNMSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 황금 추출물의 붉은덕다리버섯 균사체 발효물을 함유하는 자외선에 의한 피부 손상 억제용 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for inhibiting skin damage caused by ultraviolet rays containing a fermented product of reddissume mushroom mycelium of a golden extract.
피부 노화(skin aging)의 원인은 크게 두 가지로 나누어진다. 첫 번째는 시간이 지남에 따라 진행되는 자연적인 노화(내재적 노화, intrinsic aging)이고, 두 번째는 외부의 환경 및 자극에 의한 피부 손상으로 인한 외인성 노화이다. 외인성 노화 현상으로 자외선에 의한 노화 현상을 광노화(photoaging) 현상이라고 한다(Lee J.N., et al., 2006).There are two main causes of skin aging. The first is natural aging (intrinsic aging) that progresses over time, and the second is exogenous aging due to the external environment and skin damage caused by stimulation. The phenomenon of aging by ultraviolet rays due to extrinsic aging is called photoaging phenomenon (Lee J.N., et al., 2006).
자연적인 노화는 나이가 증가하면서 피부의 구조와 기능이 퇴행하여 피부가 건조해지며, 잔주름이 생성되고, 탄력이 소실되는 임상적인 특징을 나타내고, 조직학적으로는 표피의 위축, 표피-진피 결합부위의 편평함 및 비정상적으로 엘라스틴(elastin)의 축적이 일어난다. 광노화는 자외선(ultraviolet)에 의하여 피부 주름이 조기에 형성되고 자연적인 노화에 비해 주름이 굵고, 깊으며 그 수가 많다. 또한, 임상적으로는 피부가 건조해지며, 색소가 침착되고, 말초혈관이 확장되는 특징을 나타내며, 조직학적으로는 세포의 비전형화, 아교질의 감소, 탄력섬유가 소실되는 특징을 나타낸다(이창현, et al., 2014; 남진주, et al., 2014).Natural aging is characterized by a decrease in the structure and function of the skin with age, dryness of the skin, fine lines, and disappearance of elasticity. Histologically, epidermal atrophy, epidermal- Flatness of elastin and accumulation of elastin abnormally occur. Photo-aging is caused by ultraviolet (ultraviolet) skin wrinkles formed early, wrinkles are thicker, deeper and more numerous than natural aging. Clinically, it is characterized by dryness of the skin, deposition of pigment and expansion of peripheral blood vessels, histologically, cellular atypia, reduction of collagen, loss of elastic fibers (Lee, et al., 2014).
피부 노화에 따라 일어나는 피부 두께의 변화는 자연노화와 광노화에 따라 차이가 있다. 자연노화의 경우, 콜라겐 등의 결합 조직 합성 저하로 인해 피부 두께가 얇아지나, 자외선 등에 의한 광노화 시에는 피부의 진피층 보호를 위해 각질층의 형성이 증가하여 피부의 두께가 두꺼워진다. 자외선 등에 의한 광노화 현상으로 피부의 두께가 두꺼워졌다는 것은 그만큼 광노화에 의한 피부 손상이 크다는 것을 의미한다(Gail J., 2002). Changes in skin thickness caused by skin aging differ depending on natural aging and photoaging. In the case of natural aging, the thickness of the skin is decreased due to the decrease of the connective tissue such as collagen. However, in the case of photoaging due to ultraviolet light, the thickness of the skin becomes thicker in order to protect the dermal layer. The thickening of the skin due to photoaging due to ultraviolet light means that the skin damage due to photoaging is large (Gail J., 2002).
최근에는 환경오염으로 인해 지표면에 도달하는 자외선의 양은 해마다 증가하고 있으나 삶의 질이 향상되면서 취미 생활을 위한 야외활동이 증가하고 있다. 이에 따라, 외부 자극에 의한 피부의 노화를 방지하고, 피부 건강을 증진시킬 수 있는 다양한 방법들에 대한 관심이 커지고 있다. In recent years, the amount of ultraviolet rays reaching the ground surface due to environmental pollution has been increasing year by year, but outdoor activities for hobbies are increasing due to improved quality of life. Accordingly, there is a growing interest in various methods for preventing skin aging caused by external stimuli and for promoting skin health.
황금(Scutellaria baicalensis)은 쌍떡잎식물 통화식물목 꿀풀과의 여러해살이 식물로 동아시아 대륙이 원산지이고 한국, 중국, 시베리아 등에 주로 분포한다. 속썩은풀, 토금다금, 향수수초라고도 불리며 주 피를 벗긴 뿌리를 한약재로 사용한다. 한방에서 황금 뿌리를 해열, 이뇨, 지사, 이담 및 소염제로 이용하고 있다. 황금의 주요 활성 성분으로는 플라보노이드(flavonoid) 계열의 배당체인 바이칼린(baicalin), 우고노사이드(wogonoside)가 있고, 비배당체인 바이칼레인(baicalein)과 우고닌(wogonin)은 미량 존재하는 것으로 알려져 있는데, 배당체에 비해 비배당체 형태가 생리 활성이 높은 것으로 알려져 있다. 근래에는 상기 유효 성분들이 지니는 간세포 보호, 간경화 억제, 알코올로 인한 위 손상 억제 효과, 위산 억제, 헬리코박터 파일로리(Helicobacter pylori)균 억제, 관절 등의 통증 완화 효과 등과 같은 효능에 대한 연구들이 진행되고 있다. Golden ( Scutellaria baicalensis ) is a perennial plant of the dicotyledonous plant, monocotyledonous plant, and is widely distributed in Korea, China, and Siberia. It is also called spiny grass, almond, and fragrance. The golden roots are used as acupuncture, diuretic, branch, ejaculatory and anti-inflammatory agents in one room. It is known that baicalin and wogonoside, which are flavonoid-based glycosides, and baicalein and wogonin, which are non-glycosides, are present as major active ingredients of gold It is known that the non-glycoside form is more bioactive than the glycoside. In recent years, there have been conducted studies on the efficacy, such as the effective ingredients having liver protection, cirrhosis inhibiting, suppressing the above damage due to alcohol effects, gastric acid inhibiting, Helicobacter pylori (Helicobacter pylori) bacteria inhibited, joints and pain relief effect.
붉은덕다리버섯(Leatiporus sulphureus var. miniatus)은 담자균류의 구멍장이버섯과에 속하며, 우리나라의 백두산, 월출산, 지리산, 발왕산 등에 자생하며, 세계적으로는 일본, 아시아의 전역에 걸쳐 분포한다. 봄부터 여름까지 침엽수의 생목, 고목, 그루터기 위에 중생하는 1년생 심재 갈색 부후성 버섯이다. 붉은덕다리버섯은 예로부터 기능 조절, 건강 증진, 항질병에 효과가 있다고 전해내려 왔으나 정확한 약리 효과에 대해서는 잘 알려져 있지 않다. 붉은덕다리버섯 자실체에는 N-메틸레이티드 티라민 유도체, 다당류, 라노스테인 트리터페노이드류, 레티포릭산 및 다른 다양한 혼합물들이 포함되어 있다. 최근에는 붉은덕다리버섯이 항암 효과와 인슐린 분비 조절 효과가 있다고 보고된 바 있으며, 항암 효과로는 붉은덕다리버섯의 세포외 다당체가 암 전이 억제 및 면역력 증강을 나타내며, 이외에도 붉은덕다리버섯 균사체의 세포외 다당체는 피부 세포 성장의 생성을 촉진하고 상처치유 효과 및 피부보습 효과가 있는 것으로 알려져 있다. 특히, 붉은덕다리버섯은 글루코시다아제를 비롯한 기능성 효소를 다량 생성하는 것으로도 알려져 있다. Leatiporus sulphureus var. Miniatus is a member of the mushroom family, and it is distributed throughout Korea, Mt. Paekdusa, Wolchulsan, Jirisan, and Baewangsan. It spreads throughout Japan and Asia. From spring to summer, it is a single-year-old heartwood of coniferous trees, dead trees, and regenerated stumps. Red duck mushrooms have long been reported to be effective in controlling function, promoting health, and preventing disease, but the exact pharmacological effect is not well known. Red foxtail mushroom fruiting bodies include N-methylated tilamine derivatives, polysaccharides, lanosthenate triterpenoids, retinoic acid and various other mixtures. Recently, it has been reported that red mushroom has anticancer effect and insulin secretion regulating effect. Anticancer effect shows that extracellular polysaccharide of red mushroom shows inhibition of cancer metastasis and enhancement of immunity. In addition, the extracellular polysaccharide of red mushroom mycelium Is known to promote the production of skin cell growth and has wound healing and skin moisturizing effects. In particular, the red mushroom is known to produce a large amount of functional enzymes including glucosidase.
이에, 본 발명자는 황금 추출물의 화장료 응용 가능성을 연구하는 과정에서, 자외선 조사를 통해 피부 광노화를 유도하였고, 이러한 피부 광노화의 현상 중 하나인 피부 두께가 두꺼워지는 것을 황금 추출물을 붉은덕다리버섯 균사체로 발효한 발효물이 억제하는 것을 확인함으로써 본 발명을 완성할 수 있었다. The inventors of the present invention induced skin photoaging through ultraviolet irradiation in the process of studying the applicability of cosmetics to gold extracts, and found that the thickening of skin, which is one of the phenomena of skin photoaging, is caused by the fermentation of golden extracts into reddissolved mushroom mycelium Confirming that one fermented product is inhibited, thereby completing the present invention.
종래 선행기술로서 한국등록특허 제1521239호는 황금 붉은덕다리버섯 발효액을 유효성분으로 함유하는 피부 노화 방지 및 피부 주름 개선용 화장료 조성물을 기재하고 있으나, 본 발명의 광노화에 의한 피부 두께의 변화와 같은 피부 손상을 억제하는 효과는 기재되어 있지 않다. 또한, 한국등록특허 제1375137호 및 제1545552호는 황금 추출물의 붉은덕다리버섯 균사체 발효물을 함유하는 피부 보습 효과 및 피부 미백 효과를 기재하고 있으나, 본 발명의 광노화에 의한 피부 두께의 변화 억제 효과는 기재되어 있지 않다. Conventionally, Korean Patent No. 1521239 discloses a cosmetic composition for preventing skin aging and improving skin wrinkles containing a fermented product of golden red mildew as an active ingredient. However, in the case of skin such as change in skin thickness due to photoaging of the present invention The effect of inhibiting damage is not described. Korean Patent No. 1375137 and No. 1545552 disclose a skin moisturizing effect and a skin whitening effect containing a fermented product of reddissume mushroom mycelium of gold extract, but the effect of inhibiting the skin thickness change by photoaging of the present invention .
본 발명의 목적은 황금 추출물의 붉은덕다리버섯 균사체 발효물을 함유하는 자외선에 의한 피부 손상 억제용 화장료 조성물을 제공하는 데에 있다.It is an object of the present invention to provide a cosmetic composition for inhibiting skin damage caused by ultraviolet rays containing a fermented product of reddissume mushroom mycelium of gold extract.
본 발명은 황금(Scutellaria baicalensis) 추출물의 붉은덕다리버섯(Leatiporus sulphureus var. miniatus) 균사체 발효물을 함유하는 자외선에 의한 피부 손상 억제용 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for inhibiting skin damage caused by ultraviolet rays containing fermented mycelium of Leutipurus sulphureus var. Miniatus ( Scutellaria baicalensis ) extract.
상기 황금 추출물은 황금을 C1 내지 C4의 저급 알코올을 용매로 하여 추출한 추출물 일 수 있다. The gold extract may be an extract of gold extracted with C1 to C4 lower alcohols as a solvent.
상기 황금 추출물의 붉은덕다리버섯 균사체 발효물은 정제수에 황금 추출물을 혼합하여 제조한 발효용 배지에 붉은덕다리버섯 균사체를 접종하여 발효시킨 것일 수 있다. The fermented product of the reddish mushroom mycelium of the gold extract may be one obtained by inoculating mycelium of red mushroom with a fermentation medium prepared by mixing gold extract with purified water.
상기 발효용 배지는 정제수 100중량부에 황금 추출물 0.1~20중량부를 혼합한 것일 수 있다. The fermentation medium may be a mixture of 100 parts by weight of purified water and 0.1 to 20 parts by weight of a gold extract.
상기 피부 손상은 자외선에 의해 피부 두께가 두꺼워지는 것일 수 있다.The skin damage may be caused by thickening of the skin due to ultraviolet rays.
또한, 본 발명은 황금 추출물의 붉은덕다리버섯 균사체 발효물이 총 화장료 조성물에 0.001~30중량%가 함유되어 있는 자외선에 의한 피부 손상 억제용 화장료 조성물에 관한 것이다. Also, the present invention relates to a cosmetic composition for inhibiting skin damage caused by ultraviolet rays, wherein the fermented product of reddissume mushroom mycelium of gold extract is contained in the total cosmetic composition in an amount of 0.001 to 30% by weight.
또한, 본 발명은 상기 황금 추출물의 붉은덕다리버섯 균사체 발효물이 함유되어 있는 자외선에 의한 피부 손상 억제용 화장료 조성물을 함유하는 화장료에 관한 것이다. In addition, the present invention relates to a cosmetic composition containing a cosmetic composition for inhibiting skin damage caused by ultraviolet rays containing a fermented product of reddissume mushroom mycelium of the gold extract.
이하 본 발명을 상세하게 설명한다. Hereinafter, the present invention will be described in detail.
본 발명은 황금(Scutellaria baicalensis) 추출물의 붉은덕다리버섯(Leatiporus sulphureus var. miniatus) 균사체 발효물을 함유하는 자외선에 의한 피부 손상 억제용 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for inhibiting skin damage caused by ultraviolet rays containing fermented mycelium of Leutipurus sulphureus var. Miniatus ( Scutellaria baicalensis ) extract.
상기 황금 추출물은 황금을 C1 내지 C4의 저급 알코올을 용매로 하여 추출한 추출물일 수 있으며, 상기 C1 내지 C4의 저급 알코올은 에탄올, 메탄올, 프로판올, 이소프로판올 및 부탄올 중에서 선택될 수 있다. 바람직하게는 에탄올이며, 더욱 바람직하게는 70%[v/v] 에탄올이다. The gold extract may be an extract of gold extracted with a lower alcohol of C1 to C4 as a solvent, and the lower alcohol of C1 to C4 may be selected from ethanol, methanol, propanol, isopropanol and butanol. It is preferably ethanol, more preferably 70% [v / v] ethanol.
상기 황금 추출물은 황금에 황금 중량의 1~20배의 추출용매를 가해 상온에서 3~7일 동안 침지하여 추출액을 제조하고, 상기 추출액에서 고형분을 제거하여 여액을 수거한 후, 상기 여액을 감압농축한 농축액 또는 동결건조, 분무건조, 냉풍건조, 열풍건조 등의 방법으로 건조하여 건조물 형태로 제조할 수 있다.The gold extract is prepared by adding an extracting solvent of 1 to 20 times the weight of gold to gold and immersing it at room temperature for 3 to 7 days to prepare an extract. After removing the solid content from the extract, collecting the filtrate, the filtrate is concentrated under reduced pressure And dried by a method such as freeze-drying, spray drying, cold air drying, hot air drying, and the like.
상기 황금추출물의 붉은덕다리버섯 균사체 발효물은 정제수에 황금 추출물을 혼합하여 제조한 발효용 배지에 붉은덕다리버섯 균사체를 접종하여 발효시킴으로써 제조할 수 있으며, 상기 발효용 배지는 정제수 100중량부에 상기 황금 추출물을 0.1~20중량부를 혼합한 후, 멸균하여 제조할 수 있다. The fermented product of the reddish mushroom mycelium of the gold extract can be prepared by inoculating a fermentation medium prepared by mixing the golden extract with purified water and inoculating the red mushroom mycelium to ferment the medium. 0.1 to 20 parts by weight of the extract may be mixed and sterilized.
이때, 상기 황금 추출물은 수용액 상태로 정제수와 혼합하여 이용할 수도 있다.At this time, the gold extract may be mixed with purified water in an aqueous solution state.
황금 추출물의 붉은덕다리버섯 균사체 발효물은 상기 발효용 배지를 기준으로, 상기 붉은덕다리버섯 균사체 또는 이를 전배양(preculture)한 배양액 0.001~10중량%가 함유되어 배양 발효된 발효물일 수 있다. The fermented product of the reddish mushroom mycelium of the golden extract may be the fermented product containing the mycelium of reddissume mushroom or the precultured fermented product containing 0.001-10% by weight of the culture solution based on the fermentation medium.
또한, 본 발명은 황금 추출물을 제조하는 제1단계; 상기 황금 추출물을 붉은덕다리버섯 균사체를 이용하여 발효하는 제2단계; 및 상기 발효물로부터 붉은덕다리버섯 균사체를 제거하는 단계를 포함하는 황금 추출물의 붉은덕다리버섯 균사체 발효물의 제조 방법을 제공한다. The present invention also provides a method for producing a golden extract, comprising: a first step of preparing a gold extract; A second step of fermenting the golden extract with red mycelial fungi; And removing the reddish brown mushroom mycelium from the fermentation product. The present invention also provides a method for preparing a fermented product of a reddish mushroom mycelium of gold extract.
상기 제1단계의 황금 추출물은 농축물 상태로 이용하거나 건조물 상태로 이용할 수 있으며, 농축 또는 건조 후, 다시 정제수에 현탁하여 수용액 상태로 제조할 수 있다. The gold extract of the first step may be used in the form of a concentrate or a dried form, and may be concentrated or dried, and then suspended in purified water to prepare an aqueous solution.
상기 제2단계의 황금 추출물 발효는 정제수 100중량부에 상기 황금 추출물을 0.1~20중량부를 혼합하여 제조한 발효용 배지를 이용하여 발효할 수 있다. The fermentation of the gold extract in the second step may be performed using a fermentation medium prepared by mixing 0.1 to 20 parts by weight of the gold extract with 100 parts by weight of purified water.
상기 피부 손상은 피부가 자외선에 노출되어 나타나는 광노화의 현상일 수 있으며, 광노화에 의한 피부 손상으로 인해 피부의 두께가 두꺼워질 수 있다. The skin damage may be a phenomenon of photoaging that occurs when the skin is exposed to ultraviolet rays, and the thickness of the skin may become thick due to skin damage due to photoaging.
상기 피부 두께가 두꺼워지는 것은 자외선에 의해 피부가 손상되면, 손상된 피부를 보호하기 위해 각질층 형성이 증가하여 두꺼워지는 것일 수 있다. The thickening of the skin thickness may be due to an increase in the stratum corneum formation to protect the damaged skin when the skin is damaged by ultraviolet rays.
상기 황금 추출물의 붉은덕다리버섯 균사체 발효물은 총 화장료 조성물에 0.001~50중량%, 바람직하게는 0.001~30중량%가 함유될 수 있다. The fermented product of the reddish mushroom mycelium of the gold extract may be contained in the total cosmetic composition in an amount of 0.001 to 50% by weight, preferably 0.001 to 30% by weight.
상기 화장료 조성물은 본 발명의 황금 추출물의 붉은덕다리버섯 균사체 발효물 이외에 본 발명이 목적으로 하는 자외선에 의한 피부 손상 억제 효과를 상승시켜 줄 수 있는 다른 성분을 함유할 수 있다. The cosmetic composition of the present invention may contain, in addition to the fermented product of the red mildew of the golden extract of the present invention, other components capable of enhancing the skin damaging inhibitory effect by the ultraviolet rays of the present invention.
상기 황금 추출물의 붉은덕다리버섯 균사체 발효물은 발효 직후의 액상 상태로 화장료에 이용될 수도 있으며, 통상적인 건조 방법으로 건조된 건조물 상태로 이용될 수 있다. The fermented product of the red mildew of the golden extract may be used as a cosmetic material in a liquid state immediately after fermentation or as a dried material dried by a conventional drying method.
상기 건조 방법은 감압 건조, 동결 건조, 분무 건조, 냉풍 건조 등의 방법을 이용할 수 있다. The drying method may be vacuum drying, freeze drying, spray drying, or cold air drying.
본 발명에 따른 화장료 조성물은 화장 분야에서 통상적으로 사용되는 보조제, 예컨대 친수성 또는 친유성 겔화제, 친수성 또는 친유성 활성제, 보존제, 항산화제, 용매, 방향제, 충전제, 차단제, 안료, 흡취제 또는 염료를 함유할 수 있다. The cosmetic composition according to the present invention can be used as an adjuvant commonly used in cosmetics such as hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic active agents, preservatives, antioxidants, solvents, fragrances, fillers, ≪ / RTI >
상기 보조제의 양은 당해 분야에서 통상적으로 사용되는 양이며, 예컨대 화장료 조성물 총 중량에 대해 0.001~70중량%, 바람직하게는 0.001~50중량%이다. 다만, 어떠한 경우라도 보조제 및 그 비율은 본 발명에 따른 화장료 조성물의 바람직한 성질에 악영향을 미치지 않도록 선택될 수 있다. The amount of the adjuvant is an amount ordinarily used in the art, for example, 0.001 to 70% by weight, preferably 0.001 to 50% by weight based on the total weight of the cosmetic composition. However, in any case, the adjuvants and their proportions may be chosen so as not to adversely affect the desired properties of the cosmetic composition according to the invention.
상기 화장료 조성물은 화장수, 젤, 유용성 리퀴드, 크림, 연고 및 에센스 중에서 선택될 수 있다. The cosmetic composition may be selected from lotion, gel, oil-soluble liquid, cream, ointment and essence.
본 발명은 황금(Scutellaria baicalensis) 추출물의 붉은덕다리버섯(Leatiporus sulphureus var. miniatus) 균사체 발효물을 함유하는 자외선에 의한 피부 손상 억제용 화장료 조성물에 관한 것으로, 황금 추출물의 붉은덕다리버섯 균사체의 발효물이 자외선에 의한 광노화 현상 중 피부 손상에 의한 피부의 두께가 두꺼워지는 것을 억제함을 확인하였다. The present invention relates to a cosmetic composition for inhibiting skin damage caused by ultraviolet rays containing fermented mycelium of Leatiporus sulphureus var. Miniatus ( Scutellaria baicalensis ) extract, wherein a fermented product of a reddish-purple mushroom mycelium of gold extract It was confirmed that the thickness of the skin due to skin damage during photoaging due to ultraviolet rays is suppressed.
이에 따라, 본 발명의 황금 추출물의 붉은덕다리버섯 균사체 발효물을 이용하여 우수한 자외선에 의한 피부 손상 억제 효과가 있는 화장료 조성물을 개발할 수 있을 것으로 기대된다.Accordingly, it is expected that a cosmetic composition having an effect of suppressing skin damage due to excellent ultraviolet rays can be developed by using the fermented product of the red mildew of the golden extract of the present invention.
도 1은 본 발명의 황금 추출물의 붉은덕다리버섯 균사체의 발효물의 자외선 조사에 의해 유도된 피부 두께가 두꺼워지는 것을 억제하는 효과를 보여주고 있다. A는 자외선이 조사된 마우스의 등 피부 조직을 H&E 염색하여 피부의 두께를 관찰한 결과를, B는 마우스의 등 피부의 두께를 측정한 결과를 보여주고 있다. FIG. 1 shows the effect of suppressing the thickening of the skin thickness induced by the ultraviolet irradiation of the fermented product of the reddissume mushroom mycelium of the golden extract of the present invention. A shows the result of measuring skin thickness by H & E staining of dorsal skin tissue of a mouse irradiated with ultraviolet rays, and B shows the result of measuring the thickness of back skin of mouse.
이하 본 발명의 바람직한 실시예를 상세히 설명하기로 한다. 그러나, 본 발명은 여기서 설명되는 실시예에 한정되지 않고 다른 형태로 구체화될 수도 있다. 오히려, 여기서 소개되는 내용이 철저하고 완전해지고, 당업자에게 본 발명의 사상을 충분히 전달하기 위해 제공하는 것이다.Hereinafter, preferred embodiments of the present invention will be described in detail. However, the present invention is not limited to the embodiments described herein but may be embodied in other forms. Rather, the intention is to provide an exhaustive, complete, and complete disclosure of the principles of the invention to those skilled in the art.
<실시예 1. 황금 추출물의 제조>≪ Example 1: Preparation of golden extract >
황금은 제천한방약초에서 구입하여 사용하였다. Gold was purchased from Jecheon herb medicine.
건조된 시판 황금 100g을 충분히 세척한 다음 잘게 파쇄하고, 70%[v/v] 에탄올 1ℓ를 첨가하고, 상온에서 5일 동안 침지하여 추출물을 추출하였다. 추출물을 0.45㎛의 구멍이 있는 멤브레인 필터(membrane filter)로 여과하고, 감압 농축한 후, 동결건조하여 5.32g의 노란색 분말 형태의 황금 추출물을 제조하였다. 100 g of dried commercial gold was thoroughly washed, finely crushed, 1 l of 70% [v / v] ethanol was added, and the extract was extracted by immersion at room temperature for 5 days. The extract was filtered with a membrane filter having a pore size of 0.45 mu m, concentrated under reduced pressure, and then lyophilized to give 5.32 g of a yellow powdery golden extract.
<실시예 2. 붉은덕다리버섯 균사체의 배양>≪ Example 2: Culture of mycelia of red foxtail mushroom &
붉은덕다리버섯(Leatiporus sulphureus var. miniatus)의 초기버섯 균사체(CS0218, KFCC 1149P)는 전남 산림자원연구소에서 분양 받았다. The early mushroom mycelium (CS0218, KFCC 1149P) of the red mushroom ( Leatiporus sulphureus var. Miniatus) was distributed at Jeonnam Forest Resources Research Institute.
상기 붉은덕다리버섯 균사체는 PDA(potato dextrose agar) 사면배지에 접종 한 후 25℃에서 6일 동안 배양한 후, 이용하기 전까지 4℃에 보관하였으며, 2주 간격으로 계대 배양하였다. The mycelium of reddish brown mushroom was inoculated on a PDA (potato dextrose agar) slope medium, cultured at 25 ° C. for 6 days, stored at 4 ° C. until use, and subcultured at intervals of 2 weeks.
황금 추출물을 발효하기 위한 종균 배양물은, 사면배지에 배양한 붉은덕다리버섯 균사체를 200㎖ PDB(potato dextos broth) 배지에 접종한 후 25℃, 150rpm으로 교반하면서 7일 동안 배양하였다. The seed culture for fermenting the golden extract was inoculated into 200 ml of PDB (potato dextrose broth) medium and cultivated for 7 days with stirring at 150 rpm at 25 ° C.
<실시예 3. 황금 추출물의 붉은덕다리버섯 균사체 발효물의 제조>≪ Example 3: Preparation of fermented mycelium of reddish brown mushroom of golden extract >
본 발명의 황금 추출물의 붉은덕다리버섯 균사체 발효물은 황금 추출물이 포함된 발효용 배지에 붉은덕다리버섯 균사체를 배양함으로써 제조하였다. The fermented mycelia of reddish brown mushroom of the golden extract of the present invention was prepared by culturing mycelia of red foxtail mushroom in a fermentation medium containing a golden extract.
발효물 제조를 위해 정제수 200㎖에 상기 실시예 1의 황금 추출물 500㎎을 첨가하여 녹인 후, 2기압, 121℃에서 15분간 감압멸균하여 발효용 배지를 제조하였다. To prepare a fermented product, 500 mg of the golden extract of Example 1 was added to 200 ml of purified water, and the resulting solution was sterilized under reduced pressure at 121 캜 and 2 atm for 15 minutes to prepare a fermentation medium.
이후, 발효용 배지 200㎖에 상기 실시예 2의 배양한 붉은덕다리버섯 균사체 5㎖을 가하여 25℃, 150rpm으로 교반하면서 7일 동안 배양하여 황금 추출물을 발효하였다. 발효를 마친 후에는 원심 분리하여 얻은 붉은덕다리버섯 균사체가 모두 제거된 상층액을 동결건조하여 건조물 상태의 황금 추출물의 붉은덕다리버섯 균사체 발효물을 제조하였다. Thereafter, 5 ml of the cultured Mycorrhizal fungus cultured in Example 2 was added to 200 ml of the fermentation medium, and the mixture was incubated at 25 ° C and 150 rpm for 7 days to ferment the golden extract. After the fermentation, the supernatant, from which all the mycelia of red duck mushrooms were removed by centrifugation, was lyophilized to prepare a fermented product of reddish mushroom mycelium of the golden extract of the dried state.
<< 실험예Experimental Example 1. One. 실험 동물Experimental animal 사육> Breeding>
본 발명의 황금 추출물의 붉은덕다리버섯 균사체 발효물의 자외선에 의한 피부 손상 억제 활성을 확인하기 위해 동물 실험을 진행하였고, 이때, 6주령의 수컷 HR-1 무모(hairless) 마우스를 이용하였다. Animal experiments were carried out in order to confirm the skin-damaging activity of the golden extract of the present invention on the ultraviolet light of the fermented mycelia of red mildew. Male HR-1 hairless mice at 6 weeks of age were used.
마우스는 일본의 SLC, Inc에서 구입하였고, 1주일 동안 안정기를 가진 후에 실험에 이용하였다. 마우스 사육시 온도는 24±1℃, 습도는 50%를 유지하였고, 낮 12시간, 밤 12시간을 주기(cycle)로 하고, 먹이 및 물의 섭취는 자유롭게 하였다. Mice were purchased from SLC, Inc. of Japan and used for the experiment after having a ballast for one week. The temperature of the mice was maintained at 24 ± 1 ° C and the humidity was maintained at 50%. The mice were allowed to eat food and water for 12 hours and 12 hours at night.
<실험예 2. 자외선에 의한 피부 손상 억제 활성 확인><Experimental Example 2> Confirmation of Skin Damage Suppression Activity by Ultraviolet Light>
실험예 2-1. 시료 투여 및 피부 광노화 유도Experimental Example 2-1. Sample administration and induced skin photoaging
본 발명의 황금 추출물의 붉은덕다리버섯 균사체 발효물의 자외선에 의한 피부 손상 억제 활성을 확인하기 위해, 하기 표 1에 해당되는 실험 그룹으로 나누어 실험을 진행하였다. 상기 실험예 1의 마우스는 실험 그룹 당 3마리씩 무작위적으로 나누었다.In order to confirm the skin damage-inhibiting activity of ultraviolet rays of the fermented product of the red mildew of mycelia of golden extract of the present invention, the experiment group was divided into experimental groups corresponding to Table 1 below. The mice of Experimental Example 1 were randomly divided into three mice per experimental group.
상기 실시예 1의 황금 추출물 또는 실시예 3의 황금 추출물의 붉은덕다리버섯 균사체의 발효물을 0.4% 폴리에틸렌글리콜(polyethylene glycol)이 포함된 0.5% 에탄올로 녹인 후, 12주 동안, 1주일에 5일씩, 마우스의 등에 100㎎/㎏이 되도록 국소 도포하였다. 또한, 피부 손상을 유도하기 위해 마우스의 등에 자외선 B를 조사(radiation)하였다. 자외선 B는 12주 동안 3회 조사하였고, 1~3주까지는 60mJ/㎠로, 4~6주까지는 90mJ/㎠로, 7~12주까지는 120mJ/㎠로 5~10분간 조사하였다. The fermented product of the gold extract of Example 1 or the gold extract of Example 3 was dissolved in 0.5% ethanol containing 0.4% polyethylene glycol, and then the mixture was cultured for 12 weeks, 5 days a week , And 100 mg / kg on the back of the mouse. In addition, ultraviolet B was irradiated to the back of the mouse to induce skin damage. Ultraviolet B was irradiated three times for 12 weeks and irradiated at 60 mJ / cm 2 for 1 to 3 weeks, 90 mJ / cm 2 for 4 to 6 weeks and 120 mJ / cm 2 for 7 to 12 weeks for 5 to 10 minutes.
붉은덕다리버섯 균사체 발효물 처리군Of gold extract
Fermented Mycelium of Red Duck Mushroom
붉은덕다리버섯 균사체의 발효물 및
자외선 B 처리 The gold extract of Example 3
Fermented products of mycelia of reddish brown mushroom
UV B treatment
실험예 2-2. 피부 손상 억제 활성 확인Experimental Example 2-2. Confirm skin-damaging activity
자외선에 의해 광노화가 일어나면 피부의 두께가 두꺼워지고, 이러한 피부의 두께가 두꺼워졌다는 것은 피부의 손상이 크다는 것을 의미한다. 따라서 본 발명의 황금 추출물의 붉은덕다리버섯 균사체의 발효물의 자외선에 의한 피부 손상 억제 활성을 확인하기 위해 피부 두께의 변화를 관찰하였다.When photoaging is caused by ultraviolet rays, the thickness of the skin becomes thick, and when the thickness of the skin becomes thick, it means that the damage of the skin is great. Therefore, in order to confirm the skin damaging activity of ultraviolet rays of the fermented product of the red mildew of mycelium of gold extract of the present invention, the change of skin thickness was observed.
상기 실험예 2-1의 마우스의 등(dorsal) 피부를 떼어낸 후 10% 포르말린(formalin)으로 고정시킨 후 파라핀(paraffin) 블록을 제조하였다. 제조한 파라핀 블록을 5㎜ 두께로 절편화 하여 조직 절편을 제조하였다. The dorsal skin of the mouse of Experimental Example 2-1 was detached and fixed with 10% formalin to prepare a paraffin block. The prepared paraffin block was sectioned to a thickness of 5 mm to prepare a tissue section.
제조한 조직 절편을 H&E(hematoxylin and eosin) 염색 과정을 통해 염색한 후 현미경을 이용해 조직을 관찰하여 피부의 두께 변화를 확인하고, 접안마이크로미터(eyepiece micrometer)를 이용하여 피부 두께를 측정하여, 그 결과를 도 1에 나타내었다. The tissue slices were stained with hematoxylin and eosin (H & E) staining, and the tissue thickness was observed using a microscope. The thickness of the skin was measured and the skin thickness was measured using an eyepiece micrometer. The results are shown in Fig.
도 1의 피부 조직 관찰(A) 및 피부 두께 측정(B) 결과를 통해, 정상군에 비해 자외선 B를 조사한 대조군 1의 경우에는 피부의 두께가 두꺼워졌으나, 본 발명의 황금 추출물의 붉은덕다리버섯 균사체의 발효물을 도포한 후 자외선 B를 조사한 실험군의 경우에는, 자외선 B 조사에 의한 피부 두께의 두꺼워짐이 억제되는 것을 관찰하였다. 또한, 본 발명의 황금 추출물의 붉은덕다리버섯 균사체의 발효물의 피부 두꺼워짐 억제 효과가 황금 추출물(대조군 2) 보다도 높음을 확인하였다. The results of the skin texture observation (A) and the skin thickness measurement (B) of FIG. 1 showed that the thickness of the skin became thicker in the control group 1 irradiated with the ultraviolet ray B compared with the normal group, but the reddissume mushroom mycelium In the case of the experimental group irradiated with ultraviolet ray B, it was observed that thickening of the skin thickness due to ultraviolet ray B irradiation was suppressed. In addition, it was confirmed that the skin thickening inhibiting effect of the fermented product of the red mildew of mycorrhizal fungus extract of the present invention was higher than that of the gold extract (control 2).
이를 통해, 본 발명의 황금 추출물의 붉은덕다리버섯 균사체의 발효물이 자외선에 의한 피부 손상을 억제하는 효과가 우수하다는 것을 알 수 있었다. Thus, it was found that the fermented product of the mycelium of red mildew of the golden extract of the present invention is excellent in the effect of suppressing skin damage caused by ultraviolet rays.
<제조예 1. 화장료 제조>≪ Preparation Example 1: Preparation of cosmetic preparation >
제조예Manufacturing example 1-1. 크림 제조 1-1. Cream manufacturing
상기 실시예 3의 황금 추출물의 붉은덕다리버섯 균사체의 발효물 5g에 시토스테롤 4g, 폴리글리세릴 2-올레이트 3g, 세라마이드 0.7g, 세테아레스-4 2g, 콜레스테롤 3g, 디세틸포스페이트 0.4g, 농글리세린 5.0g, 선플라우어오일 22g, 카르복시비닐폴리머 0.5g, 트리에탄올아민 0.5g, 방부제 및 향료 미량 및 정제수를 총 무게가 100g이 되도록 혼합하였고, 통상의 크림 제조 방법에 따라 영양 크림을 제조하였다. 4 g of sitosterol, 3 g of polyglyceryl 2-olate, 0.7 g of ceramide, 2 g of cetearate-4, 3 g of cholesterol, 0.4 g of dicetyl phosphate, and concentrated glycerin were added to 5 g of the fermented product of the reddissume mushroom mycelium of Example 3, 22 g of Sunplaar oil, 0.5 g of carboxyvinyl polymer, 0.5 g of triethanolamine, a small amount of preservative and perfume, and purified water were mixed to a total weight of 100 g, and a nutritional cream was prepared according to a conventional cream preparation method.
제조예 1-2. 화장수 제조Production Example 1-2. Lotion manufacturing
95% 에탄올 8g에 폴리피롤리돈 0.05g, 올레일알콜 0.1g, 폴리옥시에틸렌모노올레이트 0.2g, 향료 0.2g, 파라옥시안식향산메틸에스테르 0.1g, 소량의 산화방지제, 소량의 색소를 혼합 용해하였다. 상기 실시예 3의 황금 추출물의 붉은덕다리버섯 균사체의 발효물 0.05g, 글리세린 5g을 정제수 85.33g에 용해한 것에 상기 혼합액을 첨가한 후 교반하여 혼합 생약의 추출물을 함유하는 화장수를 제조하였다.0.05 g of polypyrrolidone, 0.1 g of oleyl alcohol, 0.2 g of polyoxyethylene monooleate, 0.2 g of perfume, 0.1 g of p-hydroxybenzoic acid methyl ester, a small amount of antioxidant and a small amount of dye were mixed and dissolved in 8 g of 95% ethanol. 0.05 g of the fermented product of the reddissume mushroom mycelium of Example 3, and 5 g of glycerin were dissolved in 85.33 g of purified water. The mixture was added to the mixture and stirred to prepare a lotion containing the extract of the mixed herb.
제제예 1-3. 유액 제조Formulation Example 1-3. Emulsion manufacturing
세틸알코올 1.2g, 스쿠알란 10g, 바세린 2g, 파라옥시안식향산에틸에스테르 0.2g, 글리세린모노에스테아레이드 1g, 폴리옥시에틸렌(20몰부가)모노올레이트 1g 및 향료 0.1g을 70℃에서 가열혼합용해하고, 실시예 3의 황금 추출물의 붉은덕다리버섯 균사체의 발효물 0.5g, 디프로필렌글리콜 5g, 폴리에틸렌글리콜-1500 2g, 트리에탄올아민 0.2g, 정제수 76.2g을 75℃로 가열해서 용해시켰다. 양자를 혼합하여 유화시킨 후 냉각하여 수중유(O/W)형의 유액을 제조하였다.1.2 g of cetyl alcohol, 10 g of squalane, 2 g of vaseline, 0.2 g of p-hydroxybenzoic acid ethyl ester, 1 g of glycerin monoestearate, 1 g of polyoxyethylene (20 mols of addition) monooleate and 0.1 g of perfume were heated and mixed at 70 캜 , 0.5 g of the fermented product of the reddish brown mushroom mycelium of Example 3, 5 g of dipropylene glycol, 2 g of polyethylene glycol-1,500, 0.2 g of triethanolamine and 76.2 g of purified water were dissolved by heating at 75 캜. The mixture was emulsified by mixing them and then cooled to prepare oil-in-water (O / W) type emulsion.
제제예 1-4. 미용액 제조Formulation Examples 1-4. Serum preparation
95% 에틸알콜 5g에 폴리옥시에틸렌솔비탄모노올레이트 1.2g, 키툴로오즈 0.3g, 히야론산나트륨 0.2g, 비타민 E-아세테이트 0.2g, 감초산 나트륨 0.2g, 파라옥시안식향산에틸에스테르 0.1g, 상기 실시예 3의 황금 추출물의 붉은덕다리버섯 균사체의 발효물 1g 및 적량의 색소를 혼합하여 미용액을 제조하였다.To 5 g of 95% ethyl alcohol, 1.2 g of polyoxyethylene sorbitan monooleate, 0.3 g of quitrose, 0.2 g of sodium hyaluronate, 0.2 g of vitamin E-acetate, 0.2 g of sodium permanganate, 0.1 g of paraoxybenzoic acid ethyl ester, 1 g of the fermented product of the reddissume mushroom mycelium of the gold extract of Example 3 and an appropriate amount of pigment were mixed to prepare a serum.
Claims (7)
상기 황금 추출물은 황금을 C1 내지 C4의 저급 알코올을 용매로 하여 추출한 황금 추출물인 것을 특징으로 하는 자외선에 의한 피부 손상 억제용 화장료 조성물.The method according to claim 1,
Wherein the gold extract is a gold extract obtained by extracting gold from C1 to C4 lower alcohol as a solvent.
상기 황금 추출물의 붉은덕다리버섯 균사체 발효물은 정제수에 황금 추출물을 혼합하여 제조한 발효용 배지에 붉은덕다리버섯 균사체를 접종하여 발효한 것을 특징으로 하는 자외선에 의한 피부 손상 억제용 화장료 조성물.The method according to claim 1,
The cosmetic composition for inhibiting skin damage caused by ultraviolet rays is characterized in that the fermented product of reddissume mushroom mycelium of the gold extract is fermented by inoculation with a mycelium of red mushroom in a fermentation medium prepared by mixing gold extract with purified water.
상기 발효용 배지는 정제수 100중량부에 황금 추출물 0.1~20중량부를 혼합한 것을 특징으로 하는 자외선에 의한 피부 손상 억제용 화장료 조성물.The method of claim 3,
Wherein the fermentation broth is prepared by mixing 0.1 to 20 parts by weight of a golden extract with 100 parts by weight of purified water.
상기 피부 손상은 자외선에 의한 피부 두께가 두꺼워지는 것을 특징으로 하는 자외선에 의한 피부 손상 억제용 화장료 조성물.5. The method according to any one of claims 1 to 4,
Wherein the skin damage is thickened by ultraviolet rays.
A cosmetic comprising the composition of any one of claims 1 to 3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170019603A KR101957426B1 (en) | 2017-02-13 | 2017-02-13 | Cosmetic composition comprising fermented extract of Scutellaria baicalensis using Leatiporus sulphureus for inhibiting skin damage by ultraviolet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170019603A KR101957426B1 (en) | 2017-02-13 | 2017-02-13 | Cosmetic composition comprising fermented extract of Scutellaria baicalensis using Leatiporus sulphureus for inhibiting skin damage by ultraviolet |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180093465A true KR20180093465A (en) | 2018-08-22 |
KR101957426B1 KR101957426B1 (en) | 2019-03-12 |
Family
ID=63453033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170019603A KR101957426B1 (en) | 2017-02-13 | 2017-02-13 | Cosmetic composition comprising fermented extract of Scutellaria baicalensis using Leatiporus sulphureus for inhibiting skin damage by ultraviolet |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101957426B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140006494A (en) * | 2012-07-05 | 2014-01-16 | 광주여자대학교 산학협력단 | A cosmetic composition comprising fermented extract of scutellaria baicalensis using leatiporus sulphureus var. miniatus for skin moisturizing |
KR101521239B1 (en) | 2015-03-23 | 2015-06-16 | 광주여자대학교 산학협력단 | Cosmetic composition for anti-aging containing the extract of fermentative Scutellaria baicalensis by Laetiporus Sulphureus |
KR101545552B1 (en) | 2014-06-26 | 2015-08-20 | 광주여자대학교 산학협력단 | Cosmetic composition for whitening containing the extract of fermentative Scutellaria baicalensis by Laetiporus Sulphureus |
-
2017
- 2017-02-13 KR KR1020170019603A patent/KR101957426B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140006494A (en) * | 2012-07-05 | 2014-01-16 | 광주여자대학교 산학협력단 | A cosmetic composition comprising fermented extract of scutellaria baicalensis using leatiporus sulphureus var. miniatus for skin moisturizing |
KR101375137B1 (en) | 2012-07-05 | 2014-03-17 | 광주여자대학교 산학협력단 | A cosmetic composition comprising fermented extract of Scutellaria baicalensis using Leatiporus sulphureus var. miniatus for skin moisturizing |
KR101545552B1 (en) | 2014-06-26 | 2015-08-20 | 광주여자대학교 산학협력단 | Cosmetic composition for whitening containing the extract of fermentative Scutellaria baicalensis by Laetiporus Sulphureus |
KR101521239B1 (en) | 2015-03-23 | 2015-06-16 | 광주여자대학교 산학협력단 | Cosmetic composition for anti-aging containing the extract of fermentative Scutellaria baicalensis by Laetiporus Sulphureus |
Non-Patent Citations (5)
Title |
---|
European Journal of Pharmacology., vol.661, p.124-132 (2011.04.28.)* * |
Gail J., Molecular mechanism of skin ageing, Mech. Ageing Dev., 123, 801-810, 2002. |
Lee J.M., et al., Anti-wrinkle effect of Morinda citrifolia (Noni) extracts, J. Soc. Cosmet. Scientists Korea, 32, 227-231, 2006. |
남진주, et al., 능실 추출물 및 그 분획물의 피부 광노화 억제 효능, J. Soc. Cosmet. Sci. Korea, 40(4), 321-330, 2014. |
이창현, et al., 발효홍삼의 광노화 피부 억제 효과에 대한 형태학적 연구, Korean J. Oriental Physiology & Pathology, 28(2), 206-216, 2014. |
Also Published As
Publication number | Publication date |
---|---|
KR101957426B1 (en) | 2019-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2113245A2 (en) | Substances capable of potentiating laminin 5 productivity in epidermal cells and their use | |
KR101677362B1 (en) | Cosmetic composition comprising fermented Phellinus linteus extract | |
KR101390465B1 (en) | Method for Preparing Paeonia lactiflora Extracts Containing Taxifolin-3-glucoside and Cosmetic Composition Containing Preparing Paeonia lactiflora Extracts | |
KR101727788B1 (en) | Sargassum thunbergii hydrolysates that have high glucuronic acid cotent, preparation method thereof and antiaging cosmetic composition containing the same | |
KR102088728B1 (en) | Cosmetic Composition for Improving Skin Elasticity and Winkles Comprising Plant Complex Extracts as Active Ingredient | |
KR20210144725A (en) | Anti-aging, antioxidant, anti-inflammatory and whitening agents, and cosmetics | |
KR101814498B1 (en) | Cosmetic Composition Containing the Mixed Extract of Eucalyptus Globulus Leaf and Trifolium Pratense Leaf | |
KR101810410B1 (en) | Method for Preparing Extracts of Mixed Culture of Green Rye Placenta and Mushroom Mycelium and Cosmetic Composition Containing the Same | |
KR102101949B1 (en) | A skin-care agent or cosmetics containig Antrodia camphorata fruit body extract or Antrodia camphorata mycelium extract | |
KR102002997B1 (en) | Cosmetic composition including taxifolin glucosides and extracting method of paeonia lactiflora extracts | |
KR101370990B1 (en) | Anti-heat aging effect of fermented Limonia acidissima extract and its cosmetic usage to improve skin problems | |
KR100206538B1 (en) | Cosmetic composition for skin whitening containing situation mushroom powder extract | |
KR101803757B1 (en) | Cosmetic composition containing natural complex fermented extracts | |
KR101587077B1 (en) | Composition containing fermentated opuntia humifusa showing biological activity of skin | |
KR102067283B1 (en) | A skin-care agent or cosmetics containig Morchella esculenta fruit body extract or Morchella esculenta mycelium extract | |
KR20180052151A (en) | Anti-aging and anti-wrinkle of skin improving cosmetic composition comprising the extract of Sparassis crispa as an active ingredient and preparation method of the same | |
KR101957426B1 (en) | Cosmetic composition comprising fermented extract of Scutellaria baicalensis using Leatiporus sulphureus for inhibiting skin damage by ultraviolet | |
KR101931654B1 (en) | Method for preparing extract of fermented silkworm cocoon for antioxdidation and skin-whitening, and a cosmetic composition containing fermented extract of silkworm cocoon as an active ingredients | |
CN107303255B (en) | Sorghum fermentation product having anti-inflammatory, anti-allergic and atopic skin improving effects, its preparation method and cosmetic composition | |
KR102477052B1 (en) | Skin external composition containing a proteinpolysaccharide or oligo collagen peptide derived from an inula flower and the method for preparing the same | |
KR102154140B1 (en) | Composition comprising tulip leaf extract, amorphophallus paeoniifolius hydrolysis extract and parrot ferment extract | |
KR101852252B1 (en) | Method for culturing Lilium Candidum Cell and Functional skin external application comprising Lilium Candidum Cell Culture Extract | |
KR20190049067A (en) | A cosmetic composition comprising extract of coffee silver skin and coffee grounds | |
KR102073943B1 (en) | A skin-care agent or cosmetics containig Lyophyllum ulmarium fruit body extract or Lyophyllum ulmarium mycelium extract | |
KR101550309B1 (en) | Antiaging cosmetic composition containing fermented green tomato extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20170213 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20180214 Patent event code: PE09021S01D |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20180817 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20181115 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20190306 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20190306 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20221217 |